Matches in Nanopublications for { ?s ?p "DDI between Zolmitriptan and Frovatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and frovatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.